These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 13679596

  • 21. Cell-mediated immunity evaluation in foals infected with virulent equine herpesvirus-1 by multi-parameter flow cytometry.
    Platt R, Sponseller BA, Chiang YW, Roth JA.
    Vet Immunol Immunopathol; 2010 Jun 15; 135(3-4):275-81. PubMed ID: 20116862
    [Abstract] [Full Text] [Related]

  • 22. Cytokine responses to EHV-1 infection in immune and non-immune ponies.
    Coombs DK, Patton T, Kohler AK, Soboll G, Breathnach C, Townsend HG, Lunn DP.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):109-16. PubMed ID: 16473413
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant.
    Soboll Hussey G, Hussey SB, Wagner B, Horohov DW, Van de Walle GR, Osterrieder N, Goehring LS, Rao S, Lunn DP.
    Vet Res; 2011 Feb 07; 42(1):23. PubMed ID: 21314906
    [Abstract] [Full Text] [Related]

  • 25. Frequency and phenotype of EHV-1 specific, IFN-gamma synthesising lymphocytes in ponies: the effects of age, pregnancy and infection.
    Paillot R, Daly JM, Luce R, Montesso F, Davis-Poynter N, Hannant D, Kydd JH.
    Dev Comp Immunol; 2007 Feb 07; 31(2):202-14. PubMed ID: 16824599
    [Abstract] [Full Text] [Related]

  • 26. Antibody and cellular immune responses of naïve mares to repeated vaccination with an inactivated equine herpesvirus vaccine.
    Wagner B, Goodman LB, Babasyan S, Freer H, Torsteinsdóttir S, Svansson V, Björnsdóttir S, Perkins GA.
    Vaccine; 2015 Oct 13; 33(42):5588-5597. PubMed ID: 26384446
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
    Weerasinghe CU, Learmonth GS, Gilkerson JR, Foote CE, Wellington JE, Whalley JM.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):59-66. PubMed ID: 16473414
    [Abstract] [Full Text] [Related]

  • 31. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.
    Patel JR, Földi J, Bateman H, Williams J, Didlick S, Stark R.
    Vet Microbiol; 2003 Mar 20; 92(1-2):1-17. PubMed ID: 12488066
    [Abstract] [Full Text] [Related]

  • 32. Intranasal IgG4/7 antibody responses protect horses against equid herpesvirus-1 (EHV-1) infection including nasal virus shedding and cell-associated viremia.
    Perkins G, Babasyan S, Stout AE, Freer H, Rollins A, Wimer CL, Wagner B.
    Virology; 2019 May 20; 531():219-232. PubMed ID: 30928700
    [Abstract] [Full Text] [Related]

  • 33. Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1.
    Paillot R, Daly JM, Juillard V, Minke JM, Hannant D, Kydd JH.
    Vaccine; 2005 Aug 22; 23(36):4541-51. PubMed ID: 15913852
    [Abstract] [Full Text] [Related]

  • 34. Lymphocyte responses to virus and mitogen in ponies during experimental infection with equine herpesvirus 1.
    Dutta SK, Myrup A, Bumgardner MK.
    Am J Vet Res; 1980 Dec 22; 41(12):2066-8. PubMed ID: 6259978
    [Abstract] [Full Text] [Related]

  • 35. One way protection between equid herpesvirus 1 and 4 in vivo.
    Edington N, Bridges CG.
    Res Vet Sci; 1990 Mar 22; 48(2):235-9. PubMed ID: 2159176
    [Abstract] [Full Text] [Related]

  • 36. The C-terminal regions of the envelope glycoprotein gp2 of equine herpesviruses 1 and 4 are antigenically distinct.
    Learmonth GS, Love DN, Wellington JE, Gilkerson JR, Whalley JM.
    Arch Virol; 2002 Mar 22; 147(3):607-15. PubMed ID: 11958459
    [Abstract] [Full Text] [Related]

  • 37. The mucosal humoral immune response of the horse to infective challenge and vaccination with equine herpesvirus-1 antigens.
    Breathnach CC, Yeargan MR, Sheoran AS, Allen GP.
    Equine Vet J; 2001 Nov 22; 33(7):651-7. PubMed ID: 11770985
    [Abstract] [Full Text] [Related]

  • 38. Equine herpesvirus-1 infected peripheral blood mononuclear cell subpopulations during viremia.
    Wilsterman S, Soboll-Hussey G, Lunn DP, Ashton LV, Callan RJ, Hussey SB, Rao S, Goehring LS.
    Vet Microbiol; 2011 Apr 21; 149(1-2):40-7. PubMed ID: 21093993
    [Abstract] [Full Text] [Related]

  • 39. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses.
    Matsumura T, Kondo T, Sugita S, Damiani AM, O'Callaghan DJ, Imagawa H.
    Virology; 1998 Mar 01; 242(1):68-79. PubMed ID: 9501037
    [Abstract] [Full Text] [Related]

  • 40. The deletion of the ORF1 and ORF71 genes reduces virulence of the neuropathogenic EHV-1 strain Ab4 without compromising host immunity in horses.
    Wimer CL, Schnabel CL, Perkins G, Babasyan S, Freer H, Stout AE, Rollins A, Osterrieder N, Goodman LB, Glaser A, Wagner B.
    PLoS One; 2018 Mar 01; 13(11):e0206679. PubMed ID: 30440016
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.